Immunohistochemical studies showed that Uch-L1 is associated with NFT and the reduction of soluble Uch-L1 was inversely proportional to the number of NFT in AD brains (Choi et al., 2004; Chen et al., 2013). This evidence concerns the gene UCHL1 and Alzheimer disease.